Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

By News Health
3 months Ago

(MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…

Source link : https://www.medpagetoday.com/dermatology/psoriasis/116153

Author :

Publish date : 2025-06-18 20:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Overall Survival Win for Osimertinib-Chemotherapy in First-Line EGFR-Mutated NSCLC

First-Line Osimertinib Plus Chemo Extends Survival in NSCLC

NSCLC Survival Benefit Seen With EGFR-TKI + Chemo

Disabled doctors consider leaving NHS over shift inflexibility

Fracture Protection May Be Another Benefit of GLP-1 Receptor Agonists

Few Long-Term Bone Consequences After Teen Bariatric Surgery